...
首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >pH- and enzyme-triggered drug release as an important process in the design of anti-tumor drug delivery systems
【24h】

pH- and enzyme-triggered drug release as an important process in the design of anti-tumor drug delivery systems

机译:pH-和酶引发的药物释放是抗肿瘤药物递送系统设计中的重要过程

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

It is necessary to design a reasonable drug delivery system(DDS) for targeted release to overcome the potential toxicity and poor selectivity of anti-tumor drug. How a drug is released from a DDS is a critical issue that determines whether the DDS is designed successfully. We all know that the microenvironment of tumors is quite different from normal tissues, such as its acidic environment, different expression levels of some enzymes, etc. These features are widely used in the design of DDSs and play an important role in the drug release process in vivo. Numerous DDSs have been designed and synthesized. This article attention to how drugs are released from DDSs. We summarizes and classify the characteristic enzymes and chemical bonds used in the drug release process by browsing a large number of papers, and describes how they are applied in DDSs with specific examples. By understanding these acid-sensitive chemical bonds and over-expressed enzymes in tumors, different DDSs can be designed for different drug structures to solve specific problems of anti-tumor drugs.
机译:有必要设计合理的药物递送系统(DDS),用于靶向释放,以克服潜在的毒性和抗肿瘤药物的选择性差。如何从DDS释放药物是一个重要的问题,这些问题决定了DDS是否已成功设计。我们都知道肿瘤的微环境与正常组织有很大差异,例如其酸性环境,一些酶的不同表达水平等。这些特征广泛用于DDSS的设计,并在药物释放过程中发挥重要作用体内。已经设计和合成了许多DDS。这篇文章注意药物如何从DDS释放。我们通过浏览大量纸张来概述和分类药物释放过程中使用的特征酶和化学键,并描述了如何在具有具体实例的DDS中应用它们。通过了解这些酸敏感的化学键和肿瘤中的过表达酶,可以设计不同的DDS,以解决不同的药物结构,以解决抗肿瘤药物的特定问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号